Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V5BX
|
|||
Former ID |
DNC012441
|
|||
Drug Name |
NITRAQUAZONE
|
|||
Synonyms |
Nitraquazone; UNII-1YF1KXP4QF; 1YF1KXP4QF; 56739-21-0; Nitraquazonum; Nitraquazona; nitraquazone[inn]; Nitraquazone [INN]; Nitraquazonum [Latin]; Nitraquazona [Spanish]; AC1L2AEJ; CHEMBL88990; SCHEMBL125623; ZINC1819; AC1Q21K9; GNWCRBFQZDJFTI-UHFFFAOYSA-N; BDBM50218545; 3-ethyl-1-(3-nitrophenyl)quinazoline-2,4-dione; 3-Ethyl-1-(m-nitrophenyl)-2,4(1H,3H)-quinazolinedione; 1-(m-nitrophenyl)-3-ethylquinazoline-2,4 (1H, 3H)-dione; 1-(m-nitrophenyl)- 3-ethylquinazoline-2,4(1H, 3H)-dione; 1-(m-nitrophenyl)-3-ethylquinazoline-2,4(1H,
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H13N3O4
|
|||
Canonical SMILES |
CCN1C(=O)C2=CC=CC=C2N(C1=O)C3=CC(=CC=C3)[N+](=O)[O-]
|
|||
InChI |
1S/C16H13N3O4/c1-2-17-15(20)13-8-3-4-9-14(13)18(16(17)21)11-6-5-7-12(10-11)19(22)23/h3-10H,2H2,1H3
|
|||
InChIKey |
GNWCRBFQZDJFTI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 56739-21-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 4A (PDE4A) | Target Info | Inhibitor | [1] |
Phosphodiesterase 4B (PDE4B) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Purine metabolism | |||
cAMP signaling pathway | ||||
Morphine addiction | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Reactome | DARPP-32 events | |||
G alpha (s) signalling events | ||||
WikiPathways | G Protein Signaling Pathways | |||
Myometrial Relaxation and Contraction Pathways | ||||
Nuclear Receptors Meta-Pathway | ||||
Opioid Signalling |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biological evaluation of 2,5-dihydropyrazol. Bioorg Med Chem Lett. 2000 Dec 4;10(23):2661-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.